CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Toll-like receptors (TLRs) recognize molecular patterns preferentially expressed by pathogens. In endosomes, TLR9 is activated by unmethylated bacterial DNA, resulting in proinflammatory cytokine secretion via the adaptor protein MyD88. We demonstrate that CpG oligonucleotides activate a TLR9-independent pathway initiated by two Src family kinases, Hck and Lyn, which trigger a tyrosine phosphorylation–mediated signaling cascade. This cascade induces actin cytoskeleton reorganization, resulting in cell spreading, adhesion, and motility. CpG-induced actin polymerization originates at the plasma membrane, rather than in endosomes. Chloroquine, an inhibitor of CpG-triggered cytokine secretion, blocked TLR9/MyD88-dependent cytokine secretion as expected but failed to inhibit CpG-induced Src family kinase activation and its dependent cellular responses. Knock down of Src family kinase expression or the use of specific kinase inhibitors blocked MyD88-dependent signaling and cytokine secretion, providing evidence that tyrosine phosphorylation is both CpG induced and an upstream requirement for the engagement of TLR9. The Src family pathway intersects the TLR9–MyD88 pathway by promoting the tyrosine phosphorylation of TLR9 and the recruitment of Syk to this receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328 · cited 1×
“Studies using fl uorescently labeled ODNs indicate that both stimulatory and nonstimulatory ODNs are internalized nonspecifi cally, but only stimulatory ODNs activate TLR9 in endosomes, where both ligand and receptor colocalize (Hacker et al., 1998; Latz et al., 2004; Leifer et al., 2004; Takeda and Akira, 2005).”
BackgroundBacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages.
Weinstein, S. L., Gold, M. R., & DeFranco, A. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4148 · Cited by 311 · cited 2×
“…Commons@Becker: https://digitalcommons.wustl.edu/ open_access_pubs/577 T H E J O U R N A L O F C E L L B IO L O G Y JCB: ARTICLE © The Rockefeller University Press $8.00 The Journal of Cell Biology, Vol. 172, No. 7, March 27, 2006 1057–1068 http://www.jcb.org/cgi/doi/10.1083/jcb.200508058 JCB 1057”
BackgroundInfluential
Cited by
Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis
Thwaites, R., Chamberlain, G., & Sacre, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00001 · Cited by 748
Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
Behrens, E. M., Canna, S. W., Slade, K., Rao, S., Kreiger, P. A., Paessler, M., Kambayashi, T., & Koretzky, G. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43157 · Cited by 392
“Because it has been suggested that CpG motifs may trigger other receptors besides TLR9 (20), we attempted to induce disease in TLR9-deficient (Tlr9–/–) mice but found that CpG-treated Tlr9–/– mice were indistinguishable from mice injected with PBS (Supplemental Figure 2 and data not shown), thus demonstrating that thi…”
ResultDennehy, K. M., Ferwerda, G., Faro‐Trindade, I., Pyż, E., Willment, J. A., Taylor, P. R., Kerrigan, A., Tsoni, S. V., Gordon, S., Meyer‐Wentrup, F., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737741 · Cited by 373
T Lymphocyte Priming by Neutrophil Extracellular Traps Links Innate and Adaptive Immune Responses
Tillack, K., Breiden, P., Martin, R., & Sospedra, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103414 · Cited by 327
Toll-Like Receptor Pathways in Autoimmune Diseases
Chen, J.-Q., Szodoray, P., & Zeher, M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8473-z · Cited by 315
“These drugs act as antagonists of TLR9 and inhibit endosomal acidification [117].”
BackgroundBarrow, A. D., & Trowsdale, J. (2006) · European Journal of Immunology · doi:10.1002/eji.200636195 · Cited by 256
Rothfuchs, A. G., Bafica, A., Feng, C. G., Egen, J. G., Williams, D. L., Brown, G. D., & Sher, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3463 · Cited by 209
“31), 2.5 M immunostimulatory CpG, 1 g/ml Pam3Cys, 100 g/ml zymosan, or 10 g/ml LPS (all obtained from InvivoGen).”
BackgroundInfluentialRyu, C., Sun, H., Gulati, M., Herazo-Maya, J. D., Chen, Y., Osafo-Addo, A., Brandsdorfer, C., Winkler, J., Blaul, C., Faunce, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2480oc · Cited by 171
Rosa, R., Melisi, D., Damiano, V., Bianco, R., Garofalo, S., Gelardi, T., Agrawal, S., Di Nicolantonio, F., Scarpa, A., Bardelli, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3376 · Cited by 54
Metadata
- Authors
- Sanjuan, M. A., Rao, N., Lai, K.-T. A., Gu, Y., Sun, S., Fuchs, A., Fung-Leung, W.-P., Colonna, M., & Karlsson, L.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2006-03-27
- Volume
- 172
- Issue
- 7
- Pages
- 1057-1068
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2149817160
- Cited by
- 132
- References
- 4
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.